Have a personal or library account? Click to login
“New Kids on the Block” — The Game Changers. The Role of Immune Check Point Blockade in Personalised Treatment of Prostate, Urinary Bladder and Kidney Cancer Cover

“New Kids on the Block” — The Game Changers. The Role of Immune Check Point Blockade in Personalised Treatment of Prostate, Urinary Bladder and Kidney Cancer

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 75 (2021): Issue 3 (June 2021)
By: Kristofs Folkmanis,  Elizabete Junk,  Evelīna Merdane,  Valdis Folkmanis,  Inese Folkmane and  Sergejs Isajevs  
Open Access
|Jul 2021

Authors

Kristofs Folkmanis

kristofs87@inbox.lv

Faculty of Medicine, University of Latvia, Latvia
St. Bonifatius Hospital, Germany

Elizabete Junk

Faculty of Medicine, University of Latvia, Latvia
St. Bonifatius Hospital, Germany

Evelīna Merdane

Faculty of Medicine, University of Latvia, Latvia

Valdis Folkmanis

Faculty of Medicine, University of Latvia, Latvia

Inese Folkmane

Faculty of Medicine, University of Latvia, Latvia

Sergejs Isajevs

Faculty of Medicine, University of Latvia, Latvia
Rīga East University Hospital, Latvia
DOI: https://doi.org/10.2478/prolas-2021-0024 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 149 - 157
Submitted on: Jan 12, 2021
|
Accepted on: Mar 2, 2021
|
Published on: Jul 22, 2021
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
checkpoint inhibitors,
PD-L1/ PD-1 expression,
DNS mismatch repair deficiency,
microsatellite instability,
tumour mutational burden
Related subjects:
General interest,
Mathematics,
General mathematics

© 2021 Kristofs Folkmanis, Elizabete Junk, Evelīna Merdane, Valdis Folkmanis, Inese Folkmane, Sergejs Isajevs, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 75 (2021): Issue 3 (June 2021)Next article